Cancer Immunology, Immunotherapy

Local therapy of cancer with free IL-2
pp. 931-950(20)
Authors: Otter, Willem; Jacobs, John; Battermann, Jan; Hordijk, Gerrit; Krastev, Zachary; Moiseeva, Ekaterina; Stewart, Rachel; Ziekman, Paul; Koten, Jan

Tumors skew endothelial cells to disrupt NK cell, T-cell and macrophage functions
pp. 951-961(11)
Authors: Mulligan, Jennifer; Lathers, Deanne; Young, M.

CD4 and CD8 T cell responses to tumour-associated Epstein-Barr virus antigens in nasopharyngeal carcinoma patients
pp. 963-975(13)
Authors: Lin, Xiaorong; Gudgeon, Nancy; Hui, Edwin; Jia, Hui; Qun, Xue; Taylor, Graham; Barnardo, Martin; Lin, C.; Rickinson, Alan; Chan, Anthony

Vaccination of colorectal cancer patients with TroVax given alongside chemotherapy (5-fluorouracil, leukovorin and irinotecan) is safe and induces potent immune responses
pp. 977-986(10)
Authors: Harrop, Richard; Drury, Noel; Shingler, William; Chikoti, Priscilla; Redchenko, Irina; Carroll, Miles; Kingsman, Susan; Naylor, Stuart; Griffiths, Richard; Steven, Neil; Hawkins, Robert

Immune modulation by melanoma and ovarian tumor cells through expression of the immunosuppressive molecule CD200
pp. 987-996(10)
Authors: Siva, A.; Xin, H.; Qin, F.; Oltean, D.; Bowdish, K.; Kretz-Rommel, A.

Transient activation of tumor-associated T-effector/memory cells promotes tumor eradication via NK-cell recruitment: minimal role for long-term T-cell immunity in cure of metastatic disease
pp. 997-1005(9)
Authors: Gu, Tao; Kilinc, Mehmet; Egilmez, Nejat

Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF
pp. 1007-1016(10)
Authors: Yamamoto, Nobuto; Suyama, Hirofumi; Nakazato, Hiroaki; Yamamoto, Nobuyuki; Koga, Yoshihiko

A33 antigen displays persistent surface expression
pp. 1017-1027(11)
Authors: Ackerman, Margaret; Chalouni, Cecile; Schmidt, Michael; Raman, Vivek; Ritter, Gerd; Old, Lloyd; Mellman, Ira; Wittrup, K.

Activation of cytotoxic T lymphocytes against CML28-bearing tumors by dendritic cells transduced with a recombinant adeno-associated virus encoding the CML28 gene
pp. 1029-1038(10)
Authors: Xie, Li-Hua; Sin, Fion; Cheng, Samuel; Cheung, Ying-Kit; Chan, Kin-Tak; Xie, Yi; Xie, Yong

Phase I/II study of treatment with matured dendritic cells with or without low dose IL-2 in patients with disseminated melanoma
pp. 1039-1051(13)
Authors: Hersey, P.; Halliday, G.; Farrelly, M.; DeSilva, C.; Lett, M.; Menzies, S.

Rapid and potent induction of cell death and loss of NK cell cytotoxicity against oral tumors by F(ab′)₂ fragment of anti-CD16 antibody
pp. 1053-1066(14)
Authors: Jewett, Anahid; Teruel, Antonia; Romero, Marcela; Head, Christian; Cacalano, Nicholas

In vivo responses to vaccination with Mage-b, GM-CSF and thioglycollate in a highly metastatic mouse breast tumor model, 4T1
pp. 1067-1077(11)
Authors: Gravekamp, Claudia; Leal, Belinda; Denny, Ashley; Bahar, Rumana; Lampkin, Shellye; Castro, Francisco; Kim, Sun; Moore, Dan; Reddick, Robert

Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in mice
pp. 1079-1089(11)
Authors: Wondimu, Assefa; Zhang, Tianqian; Kieber-Emmons, Thomas; Gimotty, Phyllis; Sproesser, Katrin; Somasundaram, Rajasekharan; Ferrone, Soldano; Tsao, Chun-Yen; Herlyn, Dorothee

Interactions of host IL-6 and IFN-γ and cancer-derived TGF-β1 on MHC molecule expression during tumor spontaneous regression
pp. 1091-1104(14)
Authors: Hsiao, Ya-Wen; Liao, Kuang-Wen; Chung, Tien-Fu; Liu, Chen-Hsuan; Hsu, Chia-Da; Chu, Rea-Min